Guolong Luo

Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.

Yan Zhang, Yong Xu, Qiu-ping Xiang, 2022, European journal of medicinal chemistry.

Structural insights revealed by the cocrystal structure of CCS1477 in complex with CBP bromodomain.

Yan Zhang, Qiu-ping Xiang, Yong Xu, 2022, Biochemical and biophysical research communications.

Discovery and optimization of novel N-benzyl-3,6-dimethylbenzo[d]isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities.

Yan Zhang, Yong Xu, Donghai Wu, 2019, Bioorganic chemistry.

Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.

Yan Zhang, Yong Xu, X. Kong, 2021, Journal of medicinal chemistry.

Discovery of a potent and selective CBP bromodomain inhibitor (Y08262) for treating acute myeloid leukemia

Yan Zhang, Qiu-ping Xiang, Tian Wu, 2023, Bioorganic Chemistry.

Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity.

Yan Zhang, Tian Wu, Xiaoshan Chen, 2024, Journal of medicinal chemistry.